IL-4 + IL-13 were utilized together in these assays because they are both implicated in AD and signal through a common receptor pairing present on the surface of keratinocytes (IL-4Rα/IL-13Rα1) (11, 12, 30). This evidence concerns the gene IL4 and Alzheimer disease.